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Abstract Eukaryotic elongation factor 2 (EF-2) was shown to bind to F-a&n as assayed byco-sedimentation. In the presence of guanosine-5’-O- 
(3-thiotriphosphate) (GTPyS) binding was increased fourfold. At saturation level a molar atio of about 0.12 EF-2 per F-a&n (subunit) was observed. 
Our results suggest a ingle type of binding site with an apparent dissociation constant of 0.85 PM. The stoichiometry was independent ofthe filament 
length, and ADP-ribosylation had no effect on the binding. Experimental data indicated the involvement of SH-groups of both EF-2 and actin in 
the binding. The interaction EF-2 with F-a&in appeared to be inhibited competitively b  EF-la and non-competitively b  G-actin. 
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1. IntrfJduction 
Actin is an abundant cellular protein which, in filamentous 
form, plays a central role in the formation of cytoskeletal struc- 
tures [l]. A large nun&r of proteins with different characteris- 
tics and functions interact with this basic component of the 
cytoskeleton [ 1,2], regulating its assembly, interactions, and 
function(s) in the cell. 
Recent data indicate that several components of the protein 
synthetic machinery can also bind to actin microfilaments [3-81. 
Among them, elongation factor hz (EF-la), previously known 
as ABP-50 [2,f&-lo], has turned out to he a major actin-binding 
protein (ABP). The presence of elongation factor 2 (EF-2) 
along actin microfihunent bundles was shown by immunofluo- 
rescence microscopy [ 11,121. In the present study, direct 
evidence for in vitro binding of EF-2 to F-actin is reported 
together with an investigation of the interaction under different 
conditions. 
2. Materials and methods 
2.1. Materials 
EF-2 and EF-1 were prepared as described previously [13]. EF-1 
from the hydroxyapatite step was fractionated by chromatography on 
DEAE-cellulose (DE52 Whatman), and EF-la, which was not retained 
by the column, was further purified on phosphocellulose (Pll What- 
man) [14]. Both factors were pm&d to about 90% homogeneity. In 
order to prepare the nucleotide- and metal ion-free factor. EF-2 was 
additionally _ dialyzed, wherever indicated, against dialysis buffer 
(50 mM Tris-HCl, pH 7.4,0.1 mM EDTA, 7 mM 2-mercaptoethanol 
(ME) and 250 mM sucrose) with additional 5 mM EDTA. EF-2 thus 
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Abbreviations: ADPR-EF-2, adenosine diphosphate ribosylated-eukar- 
yotic elongation factor 2; EF-la, eukaryotic elongation factor la; 
F-a&in, filamentous actin; G-actin, globular actin monomer; ABP, 
actin- binding protein; DT, diphtheria toxin; DTT. dithiothreitol: 
GTP7S, guano&e-S-O-(3-thiotiothphosphate); NAD, nicotinamide ade: 
nine dinucleotide; NEM, N-ethyhnaleimide; ME, 2-mercaptoethanol; 
SDS-PAGE, sodium dodecylsulfate-polyacrylamide gel electrophore- 
sis. 
prepared was then dialysed against he dialysis buffer and this material 
is referred to as EF-2 EDTA. 
Diphtheria toxin was a gift from the Retik Saydam Institute in 
Ankara. All chemicals were purchased from Sigma Chemical Co.; ade- 
nine-[“C](U)NAD with a specific activity of 518 Ci/mol was from Du 
Pont-NEN. 
Actin was obtained from acetone powder of rabbit skeletal muscle 
following a polymerization and depolymerixation cycle; it was sepa- 
rated from contaminants bv chromatoarauhv Senhadex G-100. 1 g of 
acetone powder was resuspended in 2&25 ml (jfbuffer (5 mM potas- 
sium phosphate, pH 7.5, 0.5 mM ATP, 0.1 mM CaCl,, 0.5 mM dithio- 
threitol @‘IT), and 1 mM NaN,) and the solution was filtered through 
a Buchner funnel. G-actin was converted into the filamentous form 
(F-actin) by bringing the NaCl and MgCl, concentrations to 10 mM 
and 3 mM,~ respectively (F-buffer). Thesuspension was first incubated 
at room temnerature for 30 min and then ovemieht at 4 ‘C. F-actin was 
collected by-centrifugation at 100,080 x g for 5 h at 14°C. The pellet 
resuspended in depolymerixation buffer (2 mM potassium phosphate, 
pH 7.5, 0.5 mM ATP, 0.5 mM DTT, 0.1 mM CaCl,, 0.01 mM EDTA 
and 1 mM NaN,) was dialyzed overnight against he same buffer. The 
suspension was then homogenized with a glass homogenizer, followed 
by centrifugation at 100,000 x g for 2 h. The supematant obtained 
corresponded to the G-actin fraction. F-actin was prepared from this 
fraction by adjustment anew to F-buffer and centrifugation as indicated 
above. 
2.2. Assays 
Molar amounts of EF-2 were determined by ADP-ribosylation [ 151 
in the presence of 50 mM Tris-HCI, pH 7.4,7 mM ME, 5 PM [14C]NAD 
and 120 &ml diphtheria toxin. 
In each co-sedime-ntation experiment 200 ~1 reaction mixtures con- 
taining varying amounts of EF-2 (or ADPR-EF-2) and F-actin were 
incubated at 2@C as indicated in the figure legends. The buffer used 
consisted of 0.5 mM GTPrS. 0.5 mM ATP. 3 mM MgCl,, 10 mM NaCl, 
50 mM Tris-HCl, pH 7.4: and 10 mM ME. After incubation, reaction 
mixtures were centrifuged at 100,000 x g for 2 h and the protein content 
of the F-actin pellet was determined [16]. The amount of bound 
EF-2 was determined by ADP-ribosylation, and where binding of 
[‘4C]ADPR-EF-2 was assayed by plating aliquots directly on to GF/A 
(Whatman) filters for scintillation counter measurements. Interaction 
of EF-2 with F-actin was also investigated by SDslpAGE analysis [ 17] 
of pelleted samples. Proteins were visual&d with Coomassie brilliant 
blue, and autoradiographs of the lanes with samples incubated with 
diphtheria toxin and [i4C]NAD were obtained on Kodak X-Omat K 
films. Finally, EF-2 and actin were also detected in parallel electropho- 
resis experiments by Western blotting using anti-EF-2 and anti-actin 
antiserum, respectively [18]. The experiments reported here were re- 
peated at least twice, yielding results with minor deviations (I f 0.05). 
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Fig. 1. Effect of GTPyS on binding of EF-2 to F-actin. Incubation 
(1 h at 2O”C), was carried out as described in section 2. In the presence 
of 4.8 nmol F-actin and 60 pmol EF-2, the concentration of GTPrS was 
varied between 0 and 1 mM (c+, H). The effect of other nucleotides 
at I mM concentration are also shown; (A, A) GTP, (0, m) GDP, 
(0, +) GMP. Closed symbols, untreated EF-2; open symbols, 
EF-2 EDTA. 
3. Results 
EF-2 was found to bind to F-actin when assayed by co- 
sedimentation (Fig. I), and in the presence of GTPyS the 
amount of bound EF-2 increased twofold. Binding of EF-2 
EDTA, the nucleotide- and metal ion-free factor, in the absence 
of GTPyS, was also investigated: the amount bound to F-actin 
was reduced by half, but the nucleotide concentration depend- 
ence of the interaction followed the same trend and the satura- 
tion value was only slightly reduced. The enhancement effect 
of GTPyS was, in this case, nearly fourfold. GTP and GDP 
Table 1 
Binding of EF-2 to F-actin under different experimental conditions 
Experimental conditions EF-2 bound (pmol) 
Experiment 1 
None (control) 56.5 
EF-2MEM (5 mM, 15 min, 37°C) 27.4 
EF-2/NEM (5 mM, 30 min, 37°C) 6.1 
EF-2/DT + NAD 51.2 
EF-Zipreincubation (15 mm, 37” C) 48.9 
EF-Z/preincubation (15 mm, 60°C) 45.0 
EF-2/ME (0.7 mM, 5 min, 37°C) 71.5 
EF-2/ME (3.5 mM, 5 min, 37°C) 75.0 
Experiment 2 
None (control) 44.9 
EF-2/NEM (5 mM, 30 min, 37°C) 8.8 
F-actin/NEM (5 mM, 15 min, 37’C) 24.5 
F-actin/NEM (5 mM, 30 min, 37OC) 9.5 
Experiment 3 
None (control) 48.0 
EF-2/ME (3.5 mM) 60.1 
EF-2/ME (7.0 mM) 74.2 
EF-2/ME (10.5 mM) 77.0 
EF-2/ME (14.0 mM) 61.0 
EF-2/ME (17.5 mM) 50.5 
Binding of ADPR-EF-2 was assayed after the factor was ADP-ribosyl- 
ated by incubation for 15 min at 37°C in the presence of 5 PM 
[%]NAD and 120 ,ug/ml diphtheria toxin (DT). To assay alkylation, 
EF-2 and F-actin were preincubated with NEM and then with 7 mM 
2-mercaptoethanol (ME) prior to addition to the reaction mixture. 
NEM concentration during incubation with ME was 0.7 mM. The 
effect of freshly added ME was investigated in Experiment 1 after 
preincubation with EF-2 for indicated periods at 37°C and in Experi- 
ment 3 indicated concentrations of ME were directly added to the 
reaction mixtures. F-actin amounts used were 4.8 nmol (Experiment 1) 
and 2.4 nmol (Experiments 2and 3). The amount of EF-2 was SO pmol 
in Experiment 1 and 60 pmol in Experiments 2 and 3. The reaction 
mixtures were incubated 1 h before centrifugation and binding was 
assayed as described in section 2. 
were less effective than GTPyS, with GDP being the least 
effective agent. GMP was found to have no effect on the inter- 
action between EF-2 and F-actin. 
Effects of different experimental conditions on the binding 
A B C 
Fig. 2. SDS-PAGE analysis of the EF-2-F-a&n complex. F-a&in (100 pg) incubated with EF-2 (40 pg) was subsequently isolated by centrifugation. 
The pellet was resuspended in 50~1 buffer and 40~1 thereof was analysed electrophoretically after incubation with DT and [i4C]NAD [16]. The control 
EF-2 and the supematant fraction were subjected to ADP-ribosylation. (A) Lanes 14 show supematant of the EF-2-F-actin complex @Ofll), F-a&n 
(20 pg), EF-2. F-actin pellet resuspended in F-actin buffer (40 ,ul), and EF-2 (20 pg), respectively. (B) Autoradiograph of A. (C) Immunoblot analysis 
of gels run in parallel. EF-2 antibody staining of EF-2, EF-2. F-actin complex and F-actin are shown in lanes 1-3. Lanes 4-6 are F-actin, EF-2. F-a&n 
complex and EF-2 stained using anti-actin antibody. Arrows indicate the marker proteins; phosphorylase b (97 kDa, top band) and ovalbumin 
(45 kDa, bottom band). The middle arrow indicates the position of diphtheria toxin. 
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Fig. 3. Size-fractionation of F-actin and binding of EF-2 to F-actin fractions of defined lengths. (A) Fractionation of F-a&in according to polymer 
size on a Sepharose 4B column. The column (1 x 60 cm), developed with F-buffer, was calibrated using bovine serum albumin (BSA) (M, 67 kDa), 
ferritin (M, -450 kDa), IgM-alkaline phosphatase conjugate (M, -900 kDa), E. coli 70 S ribosome (M, -3.0 MDa) and rat liver 80 S ribosome (M, 4.5 
MDa). Elution positions of the standards were determined by measurements at A, and A,,. Elution of IgM-alkaline phosphatase was followed 
by an assay for alkaline phosphatase activity based on p-nitrophenyl-phosphate hydrolysis [19]. F-actin fractions corresponding to about 1, 2, 3,4 
and 5 MDa ? 250 kDa were pooled as indicated and collected by centrifugation at 100,000 x g for 6 h. Pellets were resuspended in polymerization 
buffer for binding experiments. (B) Binding of EF-2 to actin polymers of different length. Varying amounts of EF-2 were incubated with 4.8 nmol 
fractionated F-actin for 1 h and binding was assayed as described in section 2. Lengths of F-actin fractions were (H) 1 MDa, (c+o) 2 MDa, (A-A) 
3 MDa, (A-A) 4 MDa and (M) 5 MDa. Values are given as EF-2 bound per F-actin. (Inset B) Evaluation of the data given in B by double reciprocal 
plot as described in [20]. 
of EF-2 to F-actin are presented in Table 1, As can be seen from 
the results of Experiments 1 and 2, incubations of EF-2 with 
NEM resulted in a decrease of 90% in the amount of bound 
EF-2. Similarly, incubation of F-actin with NEM reduced the 
binding by about 80%. Results of Experiment 3 showed that 
freshly added ME enhanced the extent of interaction nearly 
twofold at an optimum concentration of 10 mM. These findings 
collectively suggest an involvement of SH-groups of both EF-2 
and F-actin in the observed interaction. A preincubation of 
EF-2 at 37 or 60°C had only a slight inhibitory effect, and 
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Fig. 4. Effect of G-actin on binding of EF-2 to F-actin. Varying amounts of EF-2 were incubated (6h at 20°C) with F-actin (2.4 nmol) in the presence 
of different amounts of G-a&in. Binding was assayed as described in section 2. (A) Evaluation of the binding data by a double reciprocal plot. G-a&n 
concentrations were; (M) OpM, (H) 2pM, (A-A) 4pM, (A-A) 8 PM. (B) Plot of the slopes obtained from A as a function of G-actin concentrations. 
ADP-ribosylation of EF-2 did not affect the binding (Experi- 
ment 1) A minor decrease observed in the latter appears to be 
due to preincubation of EF-2 at 37°C. 
The binding was also confirmed by SDS-PAGE analysis of 
F-actin, collected by ultracentrifugation after incubation with 
EF-2 (Fig. 2). A 95 kDa polypeptide, which corresponded to 
the reference EF-2 band, was hereby observed in the F-actin 
pellet fraction. Autoradiographic analysis following [14C]ADP- 
ribosylation, as well as immtmoblot analysis using anti-EF-2 
serum, supported this finding. 
In early experiments the stoichiometry of the binding was 
found to be low. This raised the question of the nature and the 
site of binding on F-a&n. In order to gain an insight into these 
features, experiments were repeated with polymer fractions of 
defined lengths obtained by chromatography on Sepharose 4B 
(Fig. 3). The amount of EF-2 bound to F-a&in subunit was not 
affected by polymer size, indicating binding along the filament. 
The stoichiometry of binding was found to be 0.12 EF-2 
bound per actin subunit. There was a single type of bind- 
ing with an apparent dissociation constant of about 0.85 PM 
(Figs. 4 and 5). G-actin inhibited binding of EF-2 to F-actin, 
suggesting an interaction of the factor with the monomer as 
well. The inhibition was non-competitive, as indicated by the 
double reciprocal plot of the binding data. A plot of the slope 
values vs. G-actin concentrations yielded a $ of 5.2 ,uM (Fig. 
4). EF-la caused, in turn, a competitive inhibition of the bind- 
ing of EF-2, which may imply identical (or overlapping) binding 
sites on F-actin. A Ki value of around 0.21 ,uM was found for 
EF-la (Fig. 5). 
4. DiscUssion 
The present investigation indicates that EF-2 is, like EF-la, 
an actin-binding protein, with an affinity comparable to that 
of several other actin-binding proteins [1,21,22]. The stoichiom- 
etry is independent of the size of the filament, suggesting bind- 
ing of the factor along the filament. These results are support- 
ed by a previous report that EF-2 is detected by indirect 
immunofluorescence microscopy along actin microfilament 
bundles [12]. 
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Fig. 5. Competitive inhibition of binding of EF-2 to F-actin by EF-la. Varying amounts of EF-2 were incubated (6 h at 2OT) with F-actin (2.4 nmol) 
in the presence of different amounts of EF-1 a. Binding was assayed as described in section 2. (A) Evaluation of the binding data by a double reciprocal 
plot. EF-la concentrations were; (O-0) 0 pM, (o-o) 0.065 PM, (A-A) 0.13 PM, (A-A) 0.26pM. (B) Plot of the slopes obtained from A as a function 
of EF-lo concentrations. 
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The physiological significance of the interaction of EF-2 with 
actin remains to be established. However, the results presented 
here and the established role of EF-la as a major act&binding 
protein [2,10] strongly suggest a possible regulatory link be- 
tween the protein synthesizing machinery and cytoskeleton. 
The much higher cellular content of actin [23] is possibly bal- 
anced by the higher affinity of EF-2 in its ribosomal interac- 
tions [24,25]. In this context, an about twofold excess of EF-2 
over ribosomes in the cell deserves special consideration 
[26-281, and our own unpublished results). 
EF-la competitively inhibits the binding of EF-2, suggesting 
common or overlapping binding sites on F-actin. Mutual exclu- 
sion of these factors on the ribosome is well known [29], but 
its significance in the case of F-actin remains obscure. Im- 
munofluorescence light microscopy, on the other hand, reveals 
important differences with regard to the cellular compartmen- 
talization of EF-la and EF-2. Whereas the former is localized 
in the cell cortex and filopodia [8], EF-2 is found mainly in the 
perinuclear region [11,12], and our own unpublished results). 
Some actin-binding proteins may be responsible for the differ- 
ent distribution of these two factors in the cell. 
GTPyS enhances the binding of EF-2 to F-actin by about 
fourfold. GTP and GDP are, in turn, less effective in promoting 
binding. The two latter nucleotides appear to have no effect on 
the binding of EF-la to F-actin [8]. EF-la is reported to exhibit 
a moderate afIinity for F-actin, with a & of 2.1 PM [7l. This 
value differs from the 4 value reported for EF-la in the present 
study. The presence of GTPyS in our competition assays may 
account for the increased affinity of EF-lee for F-actin. 
These results pose the question of how the post-synthetic 
modifications of EF-2 (i.e. ADP-ribosylation and phosphoryla- 
tion [30]) may affect the interactions of EF-2 with the cytoskel- 
eton. In this context ADP-ribosylation may be of particular 
interest since diphtheria toxin is known to give rise to fragmen- 
tation of myocardial fibrils. This effect may gain new meaning 
in the light of the reported interaction. A function of EF-2 in 
the organization of cytoskeleton may well be additionally af- 
fected by ADP-ribosylation. That ADP-ribosylation fails to 
inhibit the interaction does not yet exclude such a hypothetical 
function. 
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